 New York, New York--Newsfile Corp. - November 18, 2020 - NanoViricides, Inc. NYSE American: NNVC the Company a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, was the subject of a recent article on leading financial news website and publisher, Small Caps Daily. NanoViricides progress and advancement to clinical trials, developing a therapy to combat COVID-19 and an exploration of the technology behind NV-CoV-1, which is NanoViricides... 